© Borgis - Medycyna Rodzinna 2, p. 25-28
*Leopold ¦liwa
Mikrochimeryzm potencjaln± przyczyn± chorób autoimmunologicznych
MICROCHIMERISM A POTENTIAL CAUSE OF AUTOIMMUNE DISEASES
Zakład Biologii Rozwoju Człowieka, Instytut Pielęgniarstwa i Położnictwa, Wydział Nauk o Zdrowiu, Uniwersytet Jagielloński, Collegium Medicum w Krakowie
Kierownik Zakładu: dr hab. Leopold ¦liwa
Summary
Chimera is an organism that has two or more different populations of genetically distinct cells that originated in different zygotes. Experimentally chimeras are obtained by joining embryonic cells from the same species or even from different species. Under natural conditions chimerism is known also in humans and it is caused by the migrations of various cell types in embryonic period. During development such cell exchange between dizygotic twins as well as between embryo and mother organism is possible. This phenomenon has clinical significance and may be used in the prenatal diagnostics.
Fetal cells enter the maternal circulation during all pregnancies. The fetal cells may persist many years in their blood and tissues, resulting in microchimerism. These some cell transfer may be exist between twins children in prenatal period. It has been shown accompained with some pregnancy related disorders. Microchimerism is associated with diseases preferentially affect women and several autoimmune diseases. High levels of microchimeric cells in scleroderma led to a hypothesis postulating its contribution to disease development. Furthermore, microchimerism was observed in other autoimmune diseases. Recent reports shown then microchimeric cells are capable to capacity to differentiation and regeneration of damaged tissues in autoimmune diseases. These facts necessitate reconsideration of the first theories and give hope for new medical treatment strategies.
Key words: microchimerism, autoimmune diseases, fetal and mother cells, placental transfer
Pi¶miennictwo
1. Yaz Z et al.: Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005; 118: 899-906. 2. Haig D: What is a marmozet. Am J Primatol 1999; 49: 285-296. 3. Sourer VL et al.: A case of true hermaphroditism reveals and unusual mechanism of twinning. Human Genet 2007; 121: 179-185. 4. Szaryńska M: Mikrochimeryzm płodowo-matczyny i jego znaczenie kliniczne. Postępy Biol. Kom. 2007; 34: 85-102. 5. Thomas MR et al.: Y chromosome sequence DNA amplified from peritoneal blood of women in early pregnancy. Lancet 1994; 343: 413-414. 6. Agiga H et al.: Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy implications for noninvasive prenatal diagnosis. Transfusion 2001; 41: 1524-1530. 7. Lo YM et al.: Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 2000; 46: 1301-1309. 8. Bianchi DW et al.: Male fetal progenitur cells persist in maternal blond for as long as 27 years postpartum. Proc Natl Acad Sci USA 2003; 93: 705-708. 9. Lin H et al.: Least nicrotransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996; 87: 244-248. 10. Kaneda T et al.: Detection of maternofetal transfusion by placental alkaline phosphatase levels. J Pediatr 1997; 130: 730-735. 11. Hahn S et al.: Fetal cells and cell free nucleic AIDS in maternal blond: new tools to study abnormal placentation? Placenta 2005; 26: 515-526. 12. Bischoff FZ et al.: Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis. Human Reprod Update 2002; 8: 493-500. 13. Nelson JL: Microhimerism and human autoimmune diseases. Lupus 2002; 11: 651-654. 14. Whitacre CC: Sex differences in autoimmune disease. Nature Immunol 2001; 2: 777-780. 15. Nelson JL et al.: Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998; 351: 559-567. 16. McNallan KT et al.: Immunophenotyping of chimeric cells in localized scleroderma. Rheumatology (Oxford) 2007; 46: 398-402. 17. Scaletti C et al.: Th-2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 2002; 46: 445-450. 18. Christner PJ et al.: Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of winyl chloride. Arthritis Rheum 2000; 43: 2598-2605. 19. Mosca M et al.: Correlations of Y chromosome microchimerism with diseases activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis 2003; 62: 651-654. 20. Invernizzi P et al.: Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol 2000; 122: 418-422. 21. Renne C et al.: Thyroid fetal male microchimerism in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating limphocytes is more prevalent In Hoshimoto´s thyroiditis and Graves´ disease than In follicular adenomas. J Clin Endocrinol Metab 2004; 98: 5810-5814. 22. Nelson JL et al.: Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci USA 2007; 104: 1637-1642. 23. Stevens AM et al.: Maternal and sibling microchimerism in twins and triples discordant for neonatal lupus syndrome-congenital heart block. Rheumatology (Oxford) 2005; 44: 187-191. 24. Reed AM et al.: Does HLA-dependent chimerism underline the pathogenesis of juvenile dermatomyositis? J Immunol 2004; 172: 5041-5046.
otrzymano/received: 2009-01-06
zaakceptowano/accepted: 2009-02-02
Adres/address:
*Leopold ¦liwa
Zakład Biologii Rozwoju Człowieka Uniwersytet Jagielloński, Collegium Medicum
ul. Kopernika 7, 31-034 Kraków
tel.: (0-12) 422 99 49
e-mail: leosliwa@cm-uj.krakow.pl
